A go-to-market strategy for a wound-care innovator entering Sweden
Built an evidence-based market entry strategy for an advanced wound-management solution entering Sweden — sizing the opportunity, mapping regulatory and reimbursement requirements, and identifying the KOLs and distributors needed to launch.
- Market Landscape Assessment
- Reimbursement Landscape & Data Analytics
- Global KOL Identification & Profiling
- Global Distributor Matchmaking
The brief
Build an evidence-based market entry strategy for advanced wound care entering Sweden
- Size the Swedish opportunity
- Map the regulatory and reimbursement requirements
- Profile the high-value KOLs to engage
- Identify and evaluate distributor candidates
The ambition to enter Sweden was already settled; the gap was practical, not strategic.
The problem
No clear read on the size of the opportunity, or on the practical steps entry would demand
- Opportunity size unquantified
- Regulatory and reimbursement path undefined
- No stakeholder or distributor relationships in market
- Launch workload at risk of being underestimated
Entering without a defined plan is where market-entry timelines usually slip.
Our approach
Secondary research across market, regulation and reimbursement, validated directly with practising surgeons
- Market opportunity, regulation, reimbursement and competitive dynamics
- Five-minute express surveys with surgeons
- Treatment practices, unmet needs and adoption potential tested
- KOLs profiled on publications, clinical trials and scientific influence
Distributors were mapped and scored on capability and strategic fit in parallel.
Key outcomes
A concrete, ready-to-execute engagement plan in place of a market-entry ambition
- Quantified market opportunity assessment
- Regulatory and reimbursement roadmap with real timelines
- Curated KOL list for clinical engagement
- Shortlisted, evaluated distributor candidates
Regulatory and reimbursement proved a genuine barrier to entry, not just paperwork.
Related services
Facing a similar challenge?
Tell us what decision you're facing. We'll turn it into a clear, evidence-backed answer.
